Jaynavy Pharmaceuticals Limited
Produces and trades chemical products, drugs, and pharmaceuticals.
1987 | Ahmedabad, Gujarat (India) | Active
Jaynavy Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 0.59 M
- Company Age 38 Year, 9 Days
- Open Charges ₹ 4.53 M
About Jaynavy Pharmaceuticals
Jaynavy Pharmaceuticals Limited (JPL) is a Public Limited Indian Non-Government Company incorporated in India on 18 February 1987 and has a history of 38 years. Its registered office is in Ahmedabad, Gujarat.
The Company is engaged in the Pharma Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 0.59 M.
The company currently has active open charges totaling ₹4.53 M.
Sandeepbhai Shukla serves as a director at the Company.
Company Details
- Location Ahmedabad, Gujarat
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24231GJ1987PLC009427
- Company No.
009427
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
18 Feb 1987
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Pharma
Who are the key members and board of directors at Jaynavy Pharmaceuticals?
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sandeepbhai Shukla  | Director | 04-Sep-1995 | Current |
Financial Performance of Jaynavy Pharmaceuticals.
Enhance accessibility to Jaynavy Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Jaynavy Pharmaceuticals?
Unlock access to Jaynavy Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
Open Charges
₹0.45 Cr
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Indian Bank : 0.45 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Feb 1992 | Indian Bank | ₹2.40 M | Open |
| 06 Nov 1991 | Indian Bank | ₹1.00 M | Open |
| 03 Feb 1988 | Indian Bank | ₹0.66 M | Open |
| 02 Feb 1988 | Indian Bank | ₹0.47 M | Open |
How Many Employees Work at Jaynavy Pharmaceuticals?
Unlock and access historical data on people associated with Jaynavy Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jaynavy Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jaynavy Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.